Adcock Richard (CIK 1830328) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-24). Recent activity: Sell IBRX (77,560 shares), Buy IBRX (152,439 shares), Buy IBRX (274,122 shares), Sell IBRX (140,048 shares), Buy IBRX (34,483 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-24 | ImmunityBio, Inc. (IBRX) | CEO & President | Sell | 77,560 | $674,772 |
| 2026-02-24 | ImmunityBio, Inc. (IBRX) | CEO & President | Buy | 152,439 | $0 |
| 2026-02-12 | ImmunityBio, Inc. (IBRX) | CEO & President | Buy | 274,122 | $0 |
| 2026-02-12 | ImmunityBio, Inc. (IBRX) | CEO & President | Sell | 140,048 | $970,533 |
| 2026-01-05 | ImmunityBio, Inc. (IBRX) | CEO & President | Buy | 34,483 | $0 |
| 2026-01-05 | ImmunityBio, Inc. (IBRX) | CEO & President | Sell | 17,510 | $34,670 |
| 2025-02-25 | ImmunityBio, Inc. (IBRX) | CEO & President | Buy | 152,439 | $0 |
| 2025-02-25 | ImmunityBio, Inc. (IBRX) | CEO & President | Sell | 78,167 | $267,331 |
Source: SEC Form 4 filings · as of 2026-02-24